2 Year Absolute Returns
37.86% ↑
NAV (₹) on 09 Jun 2026
15.87
1 Day NAV Change
0.79%
Risk Level
Very High Risk
Rating
-
Kotak Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by Kotak Mahindra Asset Management Company Ltd.. Launched on 20 Nov 2023, investors can start with a ... Read more
AUM
₹ 496 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 71.52% |
| Hospitals & Medical Services | 26.13% |
| Treps/Reverse Repo | 1.41% |
| Medical Equipment & Accessories | 1.14% |
| Insurance Distributor | 0.23% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. | 14.04% | ₹ 69.62 | Pharmaceuticals |
| JB Chemicals & Pharmaceuticals Ltd. | 6.63% | ₹ 32.90 | Pharmaceuticals |
| Max Healthcare Institute Ltd. | 6.31% | ₹ 31.28 | Hospitals & Medical Services |
| Divis Laboratories Ltd. | 5.90% | ₹ 29.26 | Pharmaceuticals |
| Fortis Healthcare India Ltd | 4.84% | ₹ 24 | Hospitals & Medical Services |
| Ami Organics Ltd | 4.60% | ₹ 22.83 | Pharmaceuticals |
| Cipla Ltd. | 4.22% | ₹ 20.95 | Pharmaceuticals |
| PARK MEDI WORLD LIMITED (PARK HOSPITAL) | 3.79% | ₹ 18.79 | Hospitals & Medical Services |
| KRISHNA INSTITUTE OF MEDICAL | 3.56% | ₹ 17.67 | Hospitals & Medical Services |
| Apollo Hospitals Enterprise Ltd. | 3.08% | ₹ 15.27 | Hospitals & Medical Services |
| Lupin Ltd. | 3.02% | ₹ 14.98 | Pharmaceuticals |
| SAI LIFE SCIENCES LIMITED | 3.02% | ₹ 14.97 | Pharmaceuticals |
| MANKIND PHARMA LTD | 2.72% | ₹ 13.48 | Pharmaceuticals |
| Aurobindo Pharma Ltd. | 2.64% | ₹ 13.09 | Pharmaceuticals |
| JUBILANT PHARMOVA LIMITED | 2.52% | ₹ 12.51 | Pharmaceuticals |
| ANTHEM BIOSCIENCES LTD | 2.45% | ₹ 12.16 | Pharmaceuticals |
| Glenmark Pharmaceuticals Ltd | 2.43% | ₹ 12.03 | Pharmaceuticals |
| Ajanta Pharma Ltd. | 2.39% | ₹ 11.86 | Pharmaceuticals |
| Alkem Laboratories Ltd. | 2.07% | ₹ 10.26 | Pharmaceuticals |
| RUBICON RESEARCH LIMITED | 1.96% | ₹ 9.70 | Pharmaceuticals |
| CORONA REMEDIES LIMITED | 1.91% | ₹ 9.50 | Pharmaceuticals |
| Marksans Pharma Ltd | 1.86% | ₹ 9.23 | Pharmaceuticals |
| Gland Pharma Limited | 1.76% | ₹ 8.75 | Pharmaceuticals |
| EMCURE PHARMACEUTICALS LIMITED | 1.69% | ₹ 8.40 | Pharmaceuticals |
| YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTD | 1.49% | ₹ 7.38 | Hospitals & Medical Services |
| Triparty Repo | 1.41% | ₹ 7 | Others |
| Zydus Lifesciences Ltd. | 1.26% | ₹ 6.24 | Pharmaceuticals |
| ORCHID PHARMA LIMITED | 1.26% | ₹ 6.26 | Pharmaceuticals |
| DR.Lal Pathlabs Ltd | 1.21% | ₹ 6.02 | Hospitals & Medical Services |
| INNOVA CAPTABS LTD | 1.17% | ₹ 5.79 | Pharmaceuticals |
| LAXMI DENTAL LIMITED | 1.14% | ₹ 5.67 | Medical Equipment & Accessories |
| RAINBOW CHILDRENS MEDICARE LTD | 1.09% | ₹ 5.38 | Hospitals & Medical Services |
| METROPOLIS HEALTHCARE LTD. | 0.76% | ₹ 3.78 | Hospitals & Medical Services |
| MEDI ASSIST HEALTHCARE SERVICES LIMITED | 0.23% | ₹ 1.15 | Insurance Distributor |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 13.91% | 17.44% | 17.41% | - |
| Category returns | 1.30% | 2.21% | 6.58% | 20.44% |
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefiting directly or indirectly ... Read more
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Canara Robeco Consumption Fund
Diversified
Regular
|
₹100.48 | -9.75% | 33.09% | 71.67% | ₹1,883 | 2.06% |
Very High
|
|
Nippon India Consumption Fund
Sector
Regular
|
₹179.48 | -9.41% | 32.88% | 82.99% | ₹2,443 | 1.99% |
Very High
|
|
Nippon India Consumption Fund
Sector
Regular
|
₹179.48 | -9.41% | 32.88% | 82.99% | ₹2,443 | 1.99% |
Very High
|
|
HSBC Infrastructure Fund
Sector
Regular
|
₹35.48 | -5.92% | 32.75% | 78.30% | ₹2,441 | 2.01% |
Very High
|
|
HSBC Infrastructure Fund
Sector
Regular
|
₹35.48 | -5.92% | 32.75% | 78.30% | ₹2,441 | 2.01% |
Very High
|
|
ICICI Prudential Commodities Fund - Direct Plan
Diversified
Direct
|
₹33.32 | 5.88% | 32.70% | 49.95% | ₹3,789 | 0.95% |
Very High
|
|
ICICI Prudential Commodities Fund - Direct Plan
Diversified
Direct
|
₹33.32 | 5.88% | 32.70% | 49.95% | ₹3,789 | 0.95% |
Very High
|
|
HDFC Business Cycle Fund
Sector
Regular
|
₹14.05 | -3.76% | 32.53% | 0.00% | ₹2,577 | 1.98% |
Very High
|
|
HDFC Business Cycle Fund
Sector
Regular
|
₹14.05 | -3.76% | 32.53% | 0.00% | ₹2,577 | 1.98% |
Very High
|
|
HDFC Business Cycle Fund
Sector
Regular
|
₹14.05 | -3.76% | 32.53% | 0.00% | ₹2,577 | 1.98% |
Very High
|
What is the current NAV of Kotak Healthcare Fund - Direct Plan Growth?
What is the fund size (AUM) of Kotak Healthcare Fund - Direct Plan Growth?
What are the historical returns of Kotak Healthcare Fund - Direct Plan Growth?
What is the risk level of Kotak Healthcare Fund - Direct Plan Growth?
What is the minimum investment amount for Kotak Healthcare Fund - Direct Plan Growth?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article